Alliqua BioMedical Forecast and Stock Analysis
Technical ALQA stock analysis for February 15, 2019.
Alliqua BioMedical gained 1.83% in the last trading day, rising from $2.18 to $2.22 The price has fallen in 6 of the last 10 days and is down by -7.11% for this period. Volume fell in the last day by -7 972 shares, and in total, 15 129 shares bought and sold for approximately $33 586.40. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the ALQA stock was $2.22. This is 1.83% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 2.73% from a day low at $2.20 to a day high of $2.26.
30 day high of the ALQA stock price was $2.60 and low was $2.16.
90 day high was $5.24 and low was $1.60.
52 week high for the Alliqua BioMedical - $5.24 and low - $1.55.
Alliqua BioMedical lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.57% during the next 3 months and, with 90% probability hold a price between $2.16 and $3.73 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Alliqua BioMedical holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.25 and $2.26. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
* Golden Star Signal* is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
Alliqua BioMedical finds support from accumulated volume at $2.14.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Alliqua BioMedical stock holds several negative signals and despite the positive trend we believe Alliqua BioMedical will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.